Analyte News and Research

RSS

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.

26 Jun 2015

Aushon BioSystems announces commercial release of Ultrasensitive Cira Assays

Aushon BioSystems, a leading provider of products and services for multiplex quantitative detection of protein biomarkers, today announced the commercial release of its Ultrasensitive Cira Assays capable of measuring concentrations of low abundance proteins down to the femtogram/mL level.

2 Jun 2015

AMP report provides overview of current research on minimally invasive 'liquid biopsy' approaches

The Association for Molecular Pathology, the premier global, non-profit organization serving molecular diagnostic professionals, today published a special article in The Journal of Molecular Diagnostics titled, "Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?" The report provides a thorough overview of research to-date on the minimally invasive "liquid biopsy" approaches to cancer diagnostics.

23 Apr 2015

Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Focus Diagnostics, the clinical-laboratory products business of Quest Diagnostics, today announced the FDA 510(k) clearance and CLIA moderate-complexity categorization for its Simplexa Group A Strep Direct Kit. Simplexa Group A Strep Direct is a real-time polymerase chain reaction assay for the detection of Group A Streptococcus bacteria directly from throat swabs.

From Quest Diagnostics 15 Apr 2015

Xylem’s YSI biochemistry analyzer is effective tool for cell culture and cancer research

Specifically for oncology drug development applications, the YSI 2950 biochemistry analyzer is used to measure analytes such as glucose, glutamine, glutamate, lactate, providing a simple, automated analysis of bioprocess cell culture samples, with accurate results in less than a minute.

11 Mar 2015

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its ground-breaking in-line patient dedicated arterial blood gas analyser in Germany, Netherlands and Belgium at ISICEM 2015.

5 Mar 2015

Blood gas POCT seminar video published online by sphere medical - new clinical resources centre added to sphere medical’s website

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, has published online a video of an industry seminar on ‘True Point-of-Care Testing’ presented by Dr. Tom Clutton-Brock, Senior Lecturer Anaesthesia and Intensive Care Medicine, University Hospital Birmingham at the AAGBI 2014 Annual Congress.

10 Feb 2015

Echo Therapeutics re-establishes operational and strategic partnership with MTIA

Echo Therapeutics, Inc., a medical device company focused on skin permeation, continuous glucose monitoring, and associated technologies, announced today that it has re-established its operational and strategic partnership with Medical Technologies Innovation Asia, Ltd., Hong Kong, and has initiated the technology transfer process.

21 Jan 2015

High speed, high resolution glycan mapping now achievable for mAb characterization

The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern. Recombinant monoclonal antibody therapeutics (mAbs) represent the largest group of therapeutic proteins the analysis of the glycan pattern is therefore an essential part of the mAb characterization process.

19 Dec 2014

Clinical study of Proxima miniature in-line blood gas analyser meets primary end point

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, is pleased to announce the completion of a successful clinical study of its new Proxima miniature in-line blood gas analyser at the Queen Elizabeth Hospital, Birmingham, UK.

17 Oct 2014

MyCartis announces launch of digital multiplex biomarker analysis platform

MyCartis today announced the launch of Evalution, a multiplex biomarker analysis platform for the life sciences research market.

7 Oct 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

BIOCRATES launches first-ever bile acids kit based on targeted metabolite quantitation

Austrian BIOCRATES Life Sciences AG, internationally renowned developer and marketer of innovative targeted metabolomics solutions, further expands its range of metabolomics-based kits with the addition of its assay for the determination of endogenous bile acids, allowing a panel of up to 19 analytes to be simultaneously quantitated from a single 10 µL sample of human or mouse plasma.

1 Sep 2014

Blood test could help gauge psychosis risk

Researchers have developed a multiplex blood assay that may aid the identification of high-risk individuals who will progress to psychosis.

21 Aug 2014

Glide Pharma licenses prostate cancer diagnostic technology from FScan

Glide Pharmaceutical Technologies Ltd today announced that it has taken an exclusive worldwide licence to an innovative prostate cancer diagnostic technology from FScan Ltd, a Durham University spin-out company.

30 Jul 2014

Randox Cystatin C facilitates early detection and treatment of chronic kidney disease

As a more sensitive maker of renal dysfunction Randox Cystatin C offers several advantages over traditional creatinine assays.

From Randox Laboratories Ltd. 22 Jul 2014

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company's Acusera Immunoassay Speciality 1 quality control for use in US laboratories.

From Randox Laboratories Ltd. 22 Jul 2014

Researchers describe innovative technique for early disease detection

Despite impressive medical strides, cancer remains a leading killer and overwhelming burden to healthcare systems, causing well over a half million fatalities per year with a projected cost of $174 billion by 2020, according to the National Cancer Institute.

15 Jul 2014

Electroanalysis journal publishes a special issue about clinical diagnostics

The demand for the development of novel diagnostic tools with interest for clinical analysis is increasing.

19 Jun 2014

Electroanalysis journal publishes a special issue about clinical diagnostics

The demand for the development of novel diagnostic tools with interest for clinical analysis is increasing.

19 Jun 2014

Analyte News and Research

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

Aushon BioSystems announces commercial release of Ultrasensitive Cira Assays

AMP report provides overview of current research on minimally invasive 'liquid biopsy' approaches

Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Xylem’s YSI biochemistry analyzer is effective tool for cell culture and cancer research

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Blood gas POCT seminar video published online by sphere medical - new clinical resources centre added to sphere medical’s website

Echo Therapeutics re-establishes operational and strategic partnership with MTIA

High speed, high resolution glycan mapping now achievable for mAb characterization

Clinical study of Proxima miniature in-line blood gas analyser meets primary end point

MyCartis announces launch of digital multiplex biomarker analysis platform

Canada funds 22 inventive ideas for improving health in low-resource countries

BIOCRATES launches first-ever bile acids kit based on targeted metabolite quantitation

Blood test could help gauge psychosis risk

Glide Pharma licenses prostate cancer diagnostic technology from FScan

Randox Cystatin C facilitates early detection and treatment of chronic kidney disease

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

Researchers describe innovative technique for early disease detection

Electroanalysis journal publishes a special issue about clinical diagnostics

Electroanalysis journal publishes a special issue about clinical diagnostics

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News